MIMIX

Welcome to the Brand page for “MIMIX”, which is offered here for Pharmaceuticals, pain relief medication and hormones for medical purposes; vaccines; immunotherapies for the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of patches that provide transdermal delivery of the active ingredient for a wide range of pharmaceuticals; drug delivery agents in the form of polymers that facilitate the sustained release of a wide range of pharmaceuticals; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with vaccines; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with immunotherapies for the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with pain relief medication; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with hormones for medical purposes;.

Its status is currently believed to be active. Its class is unavailable. “MIMIX” is believed to be currently owned by “Vaxess Technologies, Inc.”